These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26497550)

  • 21. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.
    Baschnagel AM; Galoforo S; Thibodeau BJ; Ahmed S; Nirmal S; Akervall J; Wilson GD
    Anticancer Res; 2015 Nov; 35(11):5973-82. PubMed ID: 26504020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone deacetylase inhibitor AR42 regulates telomerase activity in human glioma cells via an Akt-dependent mechanism.
    Yang YL; Huang PH; Chiu HC; Kulp SK; Chen CS; Kuo CJ; Chen HD; Chen CS
    Biochem Biophys Res Commun; 2013 May; 435(1):107-12. PubMed ID: 23624506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of HSP90-dependent telomerase activity in amyloid β-induced apoptosis of cerebral endothelial cells.
    Chiu WT; Shen SC; Yang LY; Chow JM; Wu CY; Chen YC
    J Cell Physiol; 2011 Aug; 226(8):2041-51. PubMed ID: 21520056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Butylidenephthalide suppresses human telomerase reverse transcriptase (TERT) in human glioblastomas.
    Lin PC; Lin SZ; Chen YL; Chang JS; Ho LI; Liu PY; Chang LF; Harn YC; Chen SP; Sun LY; Huang PC; Chein JT; Tsai CH; Chou CW; Harn HJ; Chiou TW
    Ann Surg Oncol; 2011 Nov; 18(12):3514-27. PubMed ID: 21553143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling.
    Che Y; Li Y; Zheng F; Zou K; Li Z; Chen M; Hu S; Tian C; Yu W; Guo W; Luo M; Deng W; Zou L
    Cancer Lett; 2019 Jun; 452():1-13. PubMed ID: 30905820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human telomerase reverse transcriptase (hTERT): a target molecule for the treatment of cisplatin-resistant tumors.
    Park YP; Kim KD; Kang SH; Yoon DY; Park JW; Kim JW; Lee HG
    Korean J Lab Med; 2008 Dec; 28(6):430-7. PubMed ID: 19127107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-sitosterol-induced-apoptosis is mediated by the activation of ERK and the downregulation of Akt in MCA-102 murine fibrosarcoma cells.
    Moon DO; Lee KJ; Choi YH; Kim GY
    Int Immunopharmacol; 2007 Aug; 7(8):1044-53. PubMed ID: 17570321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
    Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
    Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementary treatment of siTERT for improving the antitumor effect of TERT-specific I-131 therapy.
    Kim S; Youn H; Song MG; Kang JH; Chung HK; Lee DS; Chung JK
    Cancer Gene Ther; 2012 Apr; 19(4):263-70. PubMed ID: 22301953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin.
    Fetz V; Bier C; Habtemichael N; Schuon R; Schweitzer A; Kunkel M; Engels K; Kovács AF; Schneider S; Mann W; Stauber RH; Knauer SK
    Int J Cancer; 2009 May; 124(9):2033-41. PubMed ID: 19130609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
    Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
    Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resveratrol causes COX-2- and p53-dependent apoptosis in head and neck squamous cell cancer cells.
    Lin HY; Sun M; Tang HY; Simone TM; Wu YH; Grandis JR; Cao HJ; Davis PJ; Davis FB
    J Cell Biochem; 2008 Aug; 104(6):2131-42. PubMed ID: 18446786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of hTERT by siRNA inhibits cervical cancer cell growth in vitro and in vivo.
    Shi YA; Zhao Q; Zhang LH; Du W; Wang XY; He X; Wu S; Li YL
    Int J Oncol; 2014 Sep; 45(3):1216-24. PubMed ID: 24920549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of telomerase by targeting MAP kinase signaling.
    Xu D; Li H; Liu JP
    Methods Mol Biol; 2007; 405():147-65. PubMed ID: 18369823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.
    Liu Y; Gao X; Deeb D; Arbab AS; Gautam SC
    Molecules; 2012 Dec; 17(12):14795-809. PubMed ID: 23519253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.